Ozempic is indicated for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise in adults. It has also been approved in 2021 by the FDA for weight loss. The common side effects are nausea, abdominal issues, dry mouth and constipation. Another side effect that is less common but … Read more
The FDA in America have approved Ritlecitinib for the treatment of severe alopecia areata (AA). This is an addition to Baricitinib which was approved a year ago by the FDA for the same condition (severe AA). These drugs act as JAK inhibitors (Janus kinase). The FDA approved dose for Ritlecitinib is 50mg once a day … Read more
A South Korean company released a new product in Europe that uses siRNA (small interfering RNA) technology to address hair loss at the genetic level. It claims to targets a protein called the androgen receptor, which binds together androgens at the hair follicle. RNA codes for proteins in the cells and the claim is that … Read more